These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18442812)
1. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812 [TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. Liu T; Peng H; Zhang M; Deng Y; Wu Z Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Liu T; Zhang M; Zhang H; Sun C; Deng Y Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509 [TBL] [Abstract][Full Text] [Related]
4. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells]. Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313 [TBL] [Abstract][Full Text] [Related]
5. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390 [TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986 [TBL] [Abstract][Full Text] [Related]
8. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines. Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715 [TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406 [TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer. Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267 [TBL] [Abstract][Full Text] [Related]
11. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy. Awasthi N; Schwarz MA; Schwarz RE Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024 [TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer. Kim HJ; Park JH; Kim JK Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378 [TBL] [Abstract][Full Text] [Related]
14. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2. Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443 [TBL] [Abstract][Full Text] [Related]
15. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effect of Cucurbitacin E on breast cancer cells. Lan T; Wang L; Xu Q; Liu W; Jin H; Mao W; Wang X; Wang X Int J Clin Exp Pathol; 2013; 6(9):1799-805. PubMed ID: 24040444 [TBL] [Abstract][Full Text] [Related]
17. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B. El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260 [TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets. Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170 [TBL] [Abstract][Full Text] [Related]
19. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. Aribi A; Gery S; Lee DH; Thoennissen NH; Thoennissen GB; Alvarez R; Ho Q; Lee K; Doan NB; Chan KT; Toh M; Said JW; Koeffler HP Int J Cancer; 2013 Jun; 132(12):2730-7. PubMed ID: 23165325 [TBL] [Abstract][Full Text] [Related]
20. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY. Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]